BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37138218)

  • 1. Functional role and epithelial to mesenchymal transition of the miR-590-3p/MDM2 axis in hepatocellular carcinoma.
    Youssef AI; Khaled GM; Amleh A
    BMC Cancer; 2023 May; 23(1):396. PubMed ID: 37138218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating RNA ZFR promotes hepatocellular carcinoma cell proliferation and epithelial-mesenchymal transition process through miR-624-3p/WEE1 axis.
    Zhang L; He S; Guan H; Zhao Y; Zhang D
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):52-63. PubMed ID: 37516591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
    Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
    Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
    Dai W; Dai JL; Tang MH; Ye MS; Fang S
    World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
    Xia YH; Ren L; Li JZ; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
    Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
    Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-30e-3p Influences Tumor Phenotype through
    Gramantieri L; Pollutri D; Gagliardi M; Giovannini C; Quarta S; Ferracin M; Casadei-Gardini A; Callegari E; De Carolis S; Marinelli S; Benevento F; Vasuri F; Ravaioli M; Cescon M; Piscaglia F; Negrini M; Bolondi L; Fornari F
    Cancer Res; 2020 Apr; 80(8):1720-1734. PubMed ID: 32015093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA LINC00342 Promotes the Proliferation, Invasion, and Migration of Primary Hepatocellular Carcinoma Cells by Regulating the Expression of miRNA-19a-3p, miRNA-545-5p, and miRNA-203a-3p.
    Yao ZX; Tu JH; Liu YL; Xue XF; Qin L
    Biochem Genet; 2024 Apr; 62(2):675-697. PubMed ID: 37395850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
    Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
    Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.
    Xu Q; Liao Z; Gong Z; Liu X; Yang Y; Wang Z; Yang W; Hou L; Yang J; Song J; Liu W; Wang B; Hua J; Pu M; Li N
    Cell Mol Biol Lett; 2022 Oct; 27(1):93. PubMed ID: 36273122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.